Fig. 3
From: Quantitative proteomics identifies and validates urinary biomarkers of rhabdomyosarcoma in children
The global proteomic profiles using DIA LC–MS/MS quantitative proteomics strategy in cohort 1. A The heatmap of global proteomic profiles and the clustering results of the samples from five different groups. B Venn diagram of proteome distribution between five groups. C Up-regulated differential proteins between Groups 1, 2, and 3. D Down-regulated differential proteins between Groups 1, 2, and 3. RN0: newly diagnosed RMS at the time points of admission. RN1 newly diagnosed RMS at the time points after 4 cycles of chemotherapy, RS0 RMS underwent surgery at the time points of admission, RS1 RMS underwent surgery at the time points after 4 cycles of chemotherapy, HC healthy control